234 related articles for article (PubMed ID: 25316811)
1. PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
Jilaveanu LB; Parisi F; Barr ML; Zito CR; Cruz-Munoz W; Kerbel RS; Rimm DL; Bosenberg MW; Halaban R; Kluger Y; Kluger HM
Clin Cancer Res; 2015 May; 21(9):2138-47. PubMed ID: 25316811
[TBL] [Abstract][Full Text] [Related]
2. PLEKHA5 regulates tumor growth in metastatic melanoma.
Zhang H; Zhu H; Deng G; Zito CR; Oria VO; Rane CK; Zhang S; Weiss SA; Tran T; Adeniran A; Zhang F; Zhou J; Kluger Y; Bosenberg MW; Kluger HM; Jilaveanu LB
Cancer; 2020 Mar; 126(5):1016-1030. PubMed ID: 31769872
[TBL] [Abstract][Full Text] [Related]
3. PLEKHA5: A Key to Unlock the Blood-Brain Barrier?
Eisele SC; Gill CM; Shankar GM; Brastianos PK
Clin Cancer Res; 2015 May; 21(9):1978-80. PubMed ID: 25779946
[TBL] [Abstract][Full Text] [Related]
4. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
[TBL] [Abstract][Full Text] [Related]
5. Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
Niessner H; Forschner A; Klumpp B; Honegger JB; Witte M; Bornemann A; Dummer R; Adam A; Bauer J; Tabatabai G; Flaherty K; Sinnberg T; Beck D; Leiter U; Mauch C; Roesch A; Weide B; Eigentler T; Schadendorf D; Garbe C; Kulms D; Quintanilla-Martinez L; Meier F
Cancer Med; 2013 Feb; 2(1):76-85. PubMed ID: 24133630
[TBL] [Abstract][Full Text] [Related]
6. Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter.
Redmer T
Mol Cancer; 2018 Jul; 17(1):106. PubMed ID: 30053879
[TBL] [Abstract][Full Text] [Related]
7. Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
Weiss SA; Zito C; Tran T; Heishima K; Neumeister V; McGuire J; Adeniran A; Kluger H; Jilaveanu LB
J Neurooncol; 2021 Mar; 152(1):15-25. PubMed ID: 32974852
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of splicing variants of PLEKHA5 (Plekha5) during brain development.
Yamada K; Nomura N; Yamano A; Yamada Y; Wakamatsu N
Gene; 2012 Jan; 492(1):270-5. PubMed ID: 22037487
[TBL] [Abstract][Full Text] [Related]
9. Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.
Kluger HM; Zito CR; Barr ML; Baine MK; Chiang VL; Sznol M; Rimm DL; Chen L; Jilaveanu LB
Clin Cancer Res; 2015 Jul; 21(13):3052-60. PubMed ID: 25788491
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
11. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
[TBL] [Abstract][Full Text] [Related]
13. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
[TBL] [Abstract][Full Text] [Related]
14. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
15. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
16. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.
Eriksson J; Le Joncour V; Jahkola T; Juteau S; Laakkonen P; Saksela O; Hölttä E
Mol Oncol; 2020 Apr; 14(4):742-762. PubMed ID: 32053263
[TBL] [Abstract][Full Text] [Related]
17. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells.
Tran TT; Rane CK; Zito CR; Weiss SA; Jessel S; Lucca L; Lu BY; Oria VO; Adeniran A; Chiang VL; Omay SB; Hafler DA; Kluger HM; Jilaveanu LB
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801444
[TBL] [Abstract][Full Text] [Related]
19. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
